COMBINATION OF NON-VIABLE CELLS OF STREPTOCOCCUS PYOGENES AND IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER AND NON-MUSCLE INVASIVE BLADDER CANCER

ACELLULAR ALLOGENIC EXOSOME PREPARATIONS AND METHODS OF USE

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

NANODELIVERY SYSTEMS FOR EXTENDED RELEASE OF ANTIBODIES

FORMULATIONS COMPRISING G-CSF AND USES THEREOF

PREPARATION FOR BIONIC INJECTABLE POLYPEPTIDE HYDROGEL AND USE THEREOF

METHODS AND COMPOSITIONS FOR SUSTAINED RELEASE MICROPARTICLES FOR OCULAR DRUG DELIVERY

SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA

HEMOPEXIN FORMULATIONS

INSTRUMENT KIT FOR TRANSOSSEOUS UPPER HYPOGASTRIC PLEXUS NEUROLYTIC BLOCKADE

A REPLICATIVE ONCOLYTIC ADENOVIROUS CAPABLE OF INHIBITING TUMOR PROGRESSION AND PROLONGING SURVIVAL TIME IN TUMOR-BEARING INDIVIDUALS AND USE THEREOF

Harnessing MicroRNAs (miRNAs) for Targeted Therapeutics in Cardiac Arrest

T CELL-TARGETED T CELLS

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES

METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER

DOUBLE-STRANDED SIRNA, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TREATING DRUG ADDICTION

ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY

METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE

GLP-1R ANTAGONISM TO IMPROVE NUTRITION FOLLOWING GASTROINTESTINAL SURGERY

METHODS OF DOSING AND ADMINISTRATION OF ENGINEERED ISLET CELLS

COMBINED TREATMENT COMPOSITION FOR TUMOR TREATMENT AND COMBINED TREATMENT METHOD

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

METHODS FOR DECREASING OR INHIBITING HUMAN L1 RETROTRANSPOSON RNA AND COMPOSITIONS FOR USE THEREIN

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

ENDOTHELIAL DAMAGE AND NANOPARTICLE TARGETING: COMPOSITIONS, PROCESSES, USES

Concentrated Injectable Tranexamic Acid Compositions and Methods of Use Thereof

STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

ANTI-GLP-1R ANTIBODIES AND USES THEREOF

APPLICATION OF ITIH1 IN PREPARATION OF DRUG FOR TREATMENT OF HEPATOCELLULAR CARCINOMA

LONG ACTING ALPHA4BETA7 TARGETING MOLECULE COMPOSITIONS FOR THE TREATMENT GASTROINTESTINAL INFLAMMATORY DISEASE

INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCER

TYROSINE KINASE INHIBITOR AND ACTIVIN TYPE 2 RECEPTOR ANTAGONIST COMBINATION THERAPY FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH)

MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF

PENTAAZA MACROCYCLIC RING COMPLEXES POSSESSING ORAL BIOAVAILABILITY

METHODS FOR THE TREATMENT OF HYPERTENSION VIA TRANSCRANIAL-FOCUSED-ULTRASOUND

TARGETED DRUG DELIVERY METHODS USING A MICRONEEDLE

ANTIBODY-DRUG CONJUGATES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

Methods for Treating Pompe Disease

Vasopressin Formulations for Use in Treatment Of Hypotension

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME

ORGANIC COMPOUNDS

METHODS OF TREATING CANCER WITH LONG-ACTING TOPOISOMERASE I INHIBITOR

ANTI-TIGIT ANTIBODY FORMULATION

COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE

COMBINATION TREATMENT FOR CANCER

COMPOSITIONS COMPRISING PREVASCULARIZED ORGANOIDS AND METHODS FOR ENHANCING ANGIOGENESIS

ANTI-PODXL ANTIBODIES FOR INHIBITING CTC CLUSTERING

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

SELECTIVE AND POTENT INHIBITORY ANTIBODIES OF MYOSTATIN ACTIVATION

HERV-K (HML-2) ENV ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE

COMPOUNDS USEFUL IN HIV THERAPY

Needle Assisted Injection Device Having Reduced Trigger Force

SYSTEM TO CREATE CELLULAR LYSIS AND DELIVER FLUIDS INTRATUMORALLY

ANTI-GALECTIN 3 ANTIBODIES AND THEIR USE IN EPILEPSY AND RELATED DISEASES

HYDROGEL COMPOSITION FOR THE TREATMENT OF PERITONEAL DISEASES

BUFFERED FORMULATIONS OF EXENDIN (9-39)

METHODS OF TREATING TUMORS

Methods Of Treating Plantar Fibromatosis

HYALURONIC ACID-BASED HYDROGELS FOR JOINT THERAPY

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

AGENTS, COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ALZHEIMER'S DISEASE

METHOD OF INITIATING SOTALOL HYDROCHLORIDE DOSING

EPINEPHRINE FORMULATIONS

COMBINATION THERAPY OF COENZYME Q10 AND RADIATION FOR TREATMENT OF GLIOMA

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

INJECTABLE TRIAMCINOLONE FORMULATIONS

METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS

SYSTEMS, COMPOSITIONS, AND METHODS RELATED TO INJECTABLE HYDROGELS

STABLE INJECTABLE CANNABIDIOL FORMULATIONS

COMPOSITIONS AND USES OF ALPHA-ADRENERGIC AGENTS

IMPROVED IGG-DEGRADING ENZYMES AND METHODS OF USE THEREOF

METHODS OF TREATING NEURODEGENERATIVE DISEASES

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS

TECHNIQUES FOR MAGNETIC NANOCLUSTER-BASED COMBINATION THERAPY

Coated element and method for coating an element

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

GJA1-20K COMPOSITIONS AND METHODS FOR MITIGATING ISCHEMIA-REPERFUSION INJURY

B CELL-SPECIFIC MAB-SIRNA CONJUGATES IMPROVE MYASTHENIA

METHODS OF VACCINATING PIGS AGAINST PSEUDORABIES VIRUS

COMBINED DELIVERY OF ANTIGENS AND TOLEROGENIC SIGNALS VIA DUAL-SIZED HYDROGEL SPHERES AND MOF COMPOSITES FOR TYPE-1 DIABETES VACCINE DEVELOPMENT

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

CANNABINOID FORMULATIONS

AN ANTIBACTERIAL PARENTERAL FORMULATION AND METHODS THEREOF

METHODS OF TREATMENT

CONTROLLED RELEASE INJECTABLE ONDANSETRON FORMULATIONS

ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING VIRAL MEDIATED DISEASE

METHODS OF ADMINISTERING R-KETAMINE

NANOSCALE MATRIMERES

HYDROGEL-BASED BIOLOGICAL DELIVERY VEHICLE

METHOD OF USING AQUEOUS SOLUTION OF PROPYLENE GLYCOL TO INHIBIT DEGRADATION OF DALBAVANCIN HYDROCHLORIDE, DALBAVANCIN INJECTION FORMULATION, PREPARATION METHOD AND METHOD OF USING THE SAME

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

CARBOHYDRATE CROSSLINKER

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies

METHOD OF TREATING INFLAMMATORY BOWEL DISEASE

INJECTABLE FORMULATIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE

ANALGESIC POLYPEPTIDE

PRAMIPEXOLE XINAFOATE AND SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION THEREOF

PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATITIS

LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE

PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL

LOW-SORBING GLYBURIDE FORMULATION AND METHODS

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

METHOD OF TREATING ORGAN DISEASES OR DISORDERS WITH ASK1 INHIBITORS

SUBCUTANEOUS FORMULATIONS COMPRISING PSILOCYBIN DERIVATIVES

Asymmetric Piperazine-Based Cationic Lipids

METHODS AND FORMULATIONS FOR TREATMENT OF LIVER CANCER USING TRIFLURIDINE

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION

Peptidomimetic Compounds, Methods for Their Preparation, and Uses Thereof

ACTIVATORS OF COAGULATION FACTOR X AND FORMULATIONS THEREOF FOR TREATING BLEEDING DISORDERS

METHODS OF PROMOTING REMYELINATION

MULTI-DOSE PEN OF TIRZEPATIDE

METHODS AND COMPOSITIONS FOR PROMOTING OPC DIFFERENTIATION AND REMYELINATION USING RECEPTOR ASSOCIATED PROTEIN (RAP)

STABLE READY TO DILUTE COMPOSITION OF CARFILZOMIB

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERS

PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA

ARIPIPRAZOLE INJECTABLE SUSPENSION FORMULATION HAVING PROLONGED SHELF LIFE

TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE

RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use

METHODS OF ADMINISTERING FVIII MIMETIC BISPECIFIC ANTIBODIES EVERY SECOND WEEK

NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION

METHODS FOR DELAYING ONSET OF TYPE 1 DIABETES

COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY

APPARATUS FOR TREATING BENIGN PROSTATIC HYPERPLASIA

BOTULINUM TOXIN PREFILLED CONTAINER

A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic colorectal cancer model

METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES

ULTRASOUND ABLATION ENHANCED BY BUBBLES FORMED FROM A CLUSTER COMPOSITION ADMINISTRATED TO A PATIENT

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY

HERPESVIRUS COMPOSITIONS AND RELATED METHODS

LIPID POLYSACCHARIDE AMINO ACID NANOPARTICLES AND USE THEREOF

ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF

STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS

READY-TO-USE POTASSIUM PHOSPHATE INJECTION

ALPHAXALONE FAT EMULSION INJECTION AND METHOD FOR PREPARING SAME

PHARMACEUTICAL COMPOSITIONS COMPRISING HIV INTEGRASE INHIBITORS

METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUCTION

METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS

FORMULATIONS OF DOCETAXEL

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

LONG-ACTING LOW-TOXICITY NOVEL CATIONIC LIPID COMPOUNDS AND COMPOSITION THEREOF

NUCLEIC ACID DRUG FOR TREATING HYPERURICEMIA-RELATED DISEASES, PREPARATION METHOD THEREFOR, AND USE THEREOF

TICAGRELOR IV FORMULATIONS FOR USE IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA

NIMODIPINE COMPOSITION FOR INJECTION

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

Medical Use of Functionalized Chitosan

COMBINATION THERAPY METHODS WITH T-CELL ENGAGING MOLECULES FOR TREATMENT OF PROSTATE CANCER

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS

FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF

FORMULATIONS OF BENDAMUSTINE

COMBINATIONS OF IMMUNOTHERAPIES AND USES THEREOF

ROTAVIRUS VACCINES

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

ONCOLYTIC VIRUS SIMULTANEOUSLY EXPRESSING CD55 AND CD59

MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS

Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

CONCENTRATED SOLUTIONS COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID

Methods For Treating Pancreatic Cancer Using Combination Therapies

INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN DRUGS

SUSTAINED-RELEASE MICROPARTICLES CONTAINING DRUG AND PAMOIC ACID

HYALURONIC ACID DERIVATIVE PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION

COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS

PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF

THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER

LEVERAGING TYPE 2 CYTOKINES TO ENHANCE CELL-BASED THERAPY FOR PERIPHERAL ARTERIAL DISEASES

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF

NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM

METHODS TO TREAT ACUTE KIDNEY INJURY WITH A FLUID

MECP2 BASED THERAPY

COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT

LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS

Method of Using r-SAK Prior to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

INCREASE OF OVUM PICK-UP IN BOS TAURUS

EXOSOMES FOR THE TREATMENT OF INTERSTITIAL CYSTITIS

ENHANCING ONCOLYTIC VIROTHERAPY WITH A COMBINATION OF NUCLEAR EXPORT INHIBITOR AND MYXOMA VIRUS ACTIVATING CELL DEATH PATHWAYS

FORMULATION COMPRISING A HOMOGENEOUS POPULATION OF MESENCHYMAL STEM CELLS AND IMPLEMENTATIONS THEREOF

COMPOSITION FOR PREVENTING OR TREATING RETINAL DEGENERATIVE DISEASE CONTAINING EXOSOMES EXTRACTED FROM MESENCHYMAL STEM CELLS

INJECTABLE ANTIBIOTIC FORMULATIONS AND USES THEREOF

FORMULATION OF AN AMPHOTERICIN B HYBRID AMIDE DERIVATIVE IN DSGPEG2K MICELLES

TREATMENT OF ANTI-VEGF REFRACTORY OPHTHALMIC RETINAL EYE CONDITIONS

3-BETA-HYDROXY-3-ALPHA-ETHYL STEROIDS FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABAA RECEPTOR

TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL

METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS

STABLE PHARMACEUTICAL COMPOSITIONS OF BENDAMUSTINE

COMPOSITIONS AND FORMULATION METHODS FOR SUSTAINED LOCAL RELEASE OF ANTIFIBROTICS

COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS

COMPOSITION FOR TREATMENT OF VITREOUS DISEASE OR DISORDER

PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT

ORELLANINE FORMULATION

DRUG DELIVERY AGENTS FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE

METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS

METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS

CD38 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

Methods For Reducing Or Preventing Cerebral Edema After Stroke

METHODS AND COMPOSITIONS OF IN VIVO ENGINEERING OF T-CELLS TO ANTI-INFLAMMATORY CELLS AND THERAPEUTIC APPLICATIONS THERE OF

TRYPTAMINE PRODRUGS

SMALL MOLECULE CONJUGATED CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY

COLLAGEN MACROPEPTIDE PREPARATIONS AND USES THEREOF

AAV-Mediated Gene Transfer for Retinopathy

USE OF BACTERIA, BACTERIAL PRODUCTS, AND OTHER IMMUNOREGULATORY ENTITIES IN COMBINATION WITH ANTI-CTLA-4 AND/OR ANTI-PD-1 ANTIBODIES TO TREAT SOLID TUMOR MALIGNANCIES

METHOD FOR TREATING OSTEOARTHRITIS WITH MESENCHYMAL STEM CELL EXOSOMES

USE OF PLATELET-BASED PRODUCTS FOR TREATMENT OF CAPSULAR CONTRACTURE PROXIMATE BREAST IMPLANT

HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-PLATINUM CHEMOPROTECTANT AGENT

HIGH ELASTICITY HYALURONAN COMPOSITIONS AND METHODS OF USE THEREOF

ORAL AND INJECTABLE FORMULATIONS OF TETRACYCLINE COMPOUNDS

SINGLE-INJECTION METHODS AND FORMULATIONS TO CONTROL THE ONSET OF ESTRUS AND OVULATION IN BOVINE, CAPRINE, OVINE, CAMELID AND OTHER FEMALE ANIMALS

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-CD3 ANTIBODY AND A CXCR3 ANTAGONIST

ALDH-2 INHIBITOR COMPOUNDS AND METHODS OF USE

Long-Lasting Anaesthetic Formulation

MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS

PREPARATION METHOD FOR LARGE-SPECIFICATION DIHYDROXYBORONPHENYLALANINE LYOPHILIZED POWDER FOR INJECTION AND LYOPHILIZED POWDER FOR INJECTION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS

METHOD OF ADMINISTRATION OF AN ANTI-IFN-ALPHA/-OMEGA ANTIBODY

ARTIFICIAL PROTEIN AND USES THEREOF

DELIVERY DEVICE

TREATMENT OF HR+/HER2- BREAST CANCER USING SACITUZUMAB GOVITECAN

CNS DELIVERY OF THERAPEUTIC AGENTS

SEMAGLUTIDE FOR USE IN MEDICINE

OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF

THERAPEUTIC COMPOSITION, ASSEMBLY KIT AND METHOD FOR THE TREATMENT OF DRY EYE DISEASE AND PROMOTION OF OCULAR HEALTH

PERITONEAL DETERIORATION INHIBITING COMPOSITION, PERITONEAL DETERIORATION INHIBITING COMPOSITION KIT, PERITONEAL DIALYSATE, PERITONEAL DIALYSATE KIT

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

SUSTAINED RELEASE SILICA HYDROGEL COMPOSITES FOR TREATING OPHTHALMOLOGICAL CONDITIONS AND METHODS OF USING SAME

AGENT FOR PREVENTING OR TREATING RESPIRATORY DISEASE

COMPOUNDS FOR TREATING INFECTIONS

LIQUID INJECTABLE COMPOSITION

OPIOID INDEPENDENT SURGICAL ANESTHETIC

READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

METHODS OF USE FOR CAR T CELLS

MEDICAL INJECTIONS AND RELATED DEVICES AND METHODS

MEDICAL INJECTIONS AND RELATED DEVICES AND METHODS

MEDICAL INJECTIONS AND RELATED DEVICES AND METHODS

VISCOSITY-REDUCING EXCIPIENT COMPOSITION AND LOW-VISCOSITY HIGHLY CONCENTRATED PROTEIN FORMULATION CONTAINING SAME

METHODS OF TREATING PANCREATIC CANCER WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE

Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins

PHARMACEUTICAL PARENTERAL COMPOSITION OF DUAL GLP1/2 AGONIST

MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF

GIP/GLP1 AGONIST COMPOSITIONS

Treatment of Warts

7DW8-5 TREATMENT FOR COVID-19 AND OTHER VIRUS-INDUCED RESPIRATORY INFECTIONS

RESCUE TREATMENT OF POST OPERATIVE NAUSEA AND VOMITING

COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS

PHARMACEUTICAL COMPOSITION

TREATMENT OF HYPERINFLAMMATORY SYNDROME

METHOD FOR REDUCING WRINKLES AND SKIN AGING PHENOMENA BY REDUCING OR PREVENTING AGING OF CELL

POLYNUCLEIC ACID MOLECULES TARGETING AGT AND USES THEREOF

C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF

PROCESSES OF MAKING 3-FLUORO-5-(((1S,2AR)-1,3,3,4,4 PENTAFLUORO-2A-HYDROXY-2,2A,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN-7-YL)OXY)BENZONITRILE AND POLYMORPHS THEREOF

SENSITIZING CELLS TO PROTON RADIATION

MICROGEL-ENCAPSULATED IPSC-DERIVED NOTOCHORDAL CELLS FOR TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND DISCOGENIC PAIN

NEW MEDICAL USE OF TAFOXIPARIN

CYTOTOXIC FLUOROPYRIMIDINE POLYMERS AND METHODS OF USE THEREOF

DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)

NOVEL METHODS

PICOLINIC-2-CARBOXAMIDE HYBRIDIZED WITH ANTHRAQUINONE DERIVATIVES, METHODS OF PREPARATION, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

INTRAVENOUS RIFABUTIN FORMULATION AND METHODS OF MAKING

NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES

EXTENDED RELEASE OF NEUREGULIN FOR TREATING HEART FAILURE

GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF HEARING LOSS

METHODS OF PRODUCING ENGINEERED IMMUNE CELLS

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

FcRn-Binding Polypeptides and Uses Thereof

GLP-1 AND GLUCAGON DUAL AGONIST PEPTIDES WITH IMPROVED BIOLOGICAL STABILITY

PURINE COMPOUNDS FOR TREATING DISORDERS

DEVICE RELATED TO THERAPEUTIC DNA DELIVERY

POLYINOSINIC- POLYCYTIDYLIC ACID COMPOSITIONS AND METHODS OF MAKING SAME

Bicistronic LAMP Constructs Comprising Immune Response Enhancing Genes and Methods of Use Thereof

Coxsackievirus B Compositions and Methods Of Use Thereof

STABLE LIQUID GONADOTROPIN FORMULATION

NOVEL COMPOSITION

CELL DELIVERY VEHICLE AND METHODS OF USING THE SAME

COMPOSITIONS OF HYALURONAN WITH HIGH ELASTICITY AND USES THEREOF

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

MDM2 DEGRADERS AND USES THEREOF

Lipid Nanoparticle Formulations for Central Nervous System Delivery